The new antibody, DISC-0974, exhibits significant selectivity for Gremlin-2, a crucial regulator playing during human differentiation. Early data reveal that blocking RGMC/HFE2 activity with DISC-0974 therapeutic https://www.targetmol.com/compound/disc_0974